Safety and Pharmacodynamcis of SELA-070 Nicotine Vaccine in Smokers
Clinical trial NCT03148925 · COMPLETED
Trial details
- NCT number
- NCT03148925
- Sponsor
- Selecta Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-11
- Primary completion
- 2018-10-18
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.